Open research questions in Poxvirus research and outbreaks
150 gap statements mined from Poxvirus research and outbreaks papers in our 4.5M-paper local library, which holds 956 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Poxvirus research and outbreaks? See the ranked Medicine journals.
What the literature leaves open
The need for a better understanding of the transmission dynamics of Monkeypox. The lack of effective control strategies for the disease. The importance of considering both human-to-human and rodent-to-human transmission pathways in the development of control strategies.
Modeling Zoonotic and Human Transmission of Mpox: Stability, Bifurcation, and Control Insights · 2026 · DOIFurther studies can be conducted to develop treatment strategies for Monkeypox using Ayurvedic principles. The concept of Anukta Vyadhi can be applied to study other emerging diseases.
The study had to overcome the limitation of a limited sample size. The study had to address the challenge of assessing knowledge and attitudes toward a emerging zoonotic threat.
Mpox Knowledge and Attitude Among Health Sciences Students in a Peruvian University https://doi.org/10.32945/atr4819.2026 · 2026 · DOIThe study had a limited sample size of 185 students. The study did not assess temporal changes in knowledge or attitudes related to the evolution of the Mpox outbreak.
Mpox Knowledge and Attitude Among Health Sciences Students in a Peruvian University https://doi.org/10.32945/atr4819.2026 · 2026 · DOIThe exact origins of Vaccinia virus remain uncertain. The driving forces behind the genomic evolution and host adaptation of Vaccinia virus are not well understood.
Phylogenetic and genome-wide analysis of codon usage reveals geographic and host-specific adaptation in Vaccinia virus · 2026 · DOIGTPV had three deeply divergent and genetically stable lineages with limited evidence of recent gene flow, whereas SPPV had weaker clade separation consistent with an ancestral bottleneck followed by recent population expansion.
Future research could explore integrating 3D, hyperspectral, or dermoscopic imaging modalities to provide deeper morphological insights into lesion characteristics, potentially improving classification accuracy and enabling more nuanced differentiation between monkeypox and other visually similar skin conditions.
Although BPoPV disease has been reported in different regions of Brazil6–9, the frequency of infection in wild BP populations has not been established.
Investigating the emergence of the Brazilian porcupinepox poxvirus in wild Brazilian porcupines (Coendou longicaudatus) · 2026 · DOILimited disease-specific knowledge among university students. Gaps in transmission routes, clinical recognition, prevention, and vaccination awareness.
Mpox-Related Knowledge, Risk Perception, and Vaccination Willingness Among University Students in Aktobe, Kazakhstan: A Cross-Sectional Study · 2026 · DOIWhile silent transmission represents a major challenge for mpox prevention and control in low-incidence areas, it remains understudied despite its importance for public health practice (13).
Mpox-HIV co-infection in a low-incidence setting: epidemiological insights from Qinghai, China · 2026 · DOIFurther study of the transmission dynamics and genetic variability of the monkeypox virus is necessary. Global cooperation and monitoring are necessary to prevent the spread of mpox. The development of effective vaccines and treatments is crucial to contain the disease.
An Emerging Global Threat After The COVID-19 Pandemic: Monkeypox Similarities and Differences · 2026 · DOIHowever, orthopoxvirus surfaces are complex, displaying many antigens across two infectious forms, mature virions (MV) and extracellular virions (EV) and targets relevant to protection remain to be comprehensively defined.
Comprehensive Profiling of Monkeypox Virus Antigens Identifies Potent Targets for Next-Generation mRNA Vaccine Development · 2026 · DOIThe lack of a universally accepted serological gold standard for classification of prior MPXV exposure. The complexity and cost of multiplex assays.
A simplified antigen-based serological algorithm accurately classifies MPXV exposure and vaccination status · 2026 · DOIThere is a need for reliable serological tools to measure MPXV exposure and evaluate vaccine-induced immunity. The relative diagnostic contribution of individual antigens has not been well defined.
A simplified antigen-based serological algorithm accurately classifies MPXV exposure and vaccination status · 2026 · DOIThe difference in virulence of MPXV subclades in human infection warrants further investigation; however, one critical limitation is the lack of susceptible small animal models.
Monkeypox virus clade IIb isolate exhibits reduced virulence relative to clade IIa isolates in multiple murine models · 2026 · DOIThere is a need to evaluate the safety of the Jynneos vaccine. The study fills the gap by providing a safety profile of the vaccine in the vaccinated high-risk population.
Vaccine safety surveillance during an mpox outbreak, Germany, June 2022 to February 2024 · 2026 · DOIFurther studies should focus on the development of effective public health policies for controlling Mpox. Research should prioritize the use of a One Health approach in controlling the disease.
There is a need for further research on the transmission and diagnosis of Mpox. The importance of a One Health approach in controlling the disease requires further emphasis.
Few vaccine platforms have demonstrated robust and durable immune responses against pathogens spanning distinct biological classes. Existing malaria vaccines have moderate efficacy and waning durability. SARS-CoV-2 vaccine coverage has lagged behind in sub-Saharan Africa due to supply shortages, cold-chain limitations, and distribution challenges.
A viral-vectored multipathogen vaccine platform based on replication-competent vaccinia virus and adeno-associated virus · 2026 · DOIIntroduction Monkeypox virus (MPXV) infection induces robust humoral immune responses; however, the kinetics of IgG avidity maturation following natural infection remain poorly characterized.
The lack of effective methods for disease surveillance in domestic/wild animals. The need for non-invasive and efficient methods for disease surveillance.
Insect-derived environmental surveillance of lumpy skin disease virus using synanthropic flies · 2026 · DOIIn Vitro Enzyme Inhibition Assays will be conducted to assess the biochemical activity of the MPXV DNA polymerase, - IC50 values of each compound will be determined by measuring the inhibition of polymerase activity across a range of compound…
Computational Discovery of Novel Monkeypox Virus DNA Polymerase Inhibitors from the Zinc20 Database · 2026 · DOIFurther study of the evolution and adaptation of Vaccinia virus. Analysis of the role of natural selection and mutational pressure in shaping codon usage patterns. Investigation of the implications of the study's findings for public health policy and disease control strategies.
Phylogenetic and genome-wide analysis of codon usage reveals geographic and host-specific adaptation in Vaccinia virus · 2026 · DOIThe study was conducted among university students in Aktobe, Kazakhstan, - The sample size was limited to 482 respondents, - The study used a cross-sectional design, - The study relied on self-reported…
Mpox-Related Knowledge, Risk Perception, and Vaccination Willingness Among University Students in Aktobe, Kazakhstan: A Cross-Sectional Study · 2026 · DOIFurther studies on the molecular aspects of pathogenesis, evolution, transmission, and epidemiology of MPXV clades. Development of effective vaccines and public health strategies.
Mpox Virus Variants Clade-I and Clade-II Pathogenesis: Mapping the Genetic Mutations, Impact on Viral Fitness, Efficiency of Human-To-Human Transmission, Epidemiological Surveillance · 2026 · DOI
Most-cited papers in Poxvirus research and outbreaks
- Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 · New England Journal of Medicine · 2022 · 1,854 citations
- Prevention and Treatment of Monkeypox · Drugs · 2022 · 500 citations
- Emergence of Monkeypox — West and Central Africa, 1970–2017 · MMWR Morbidity and Mortality Weekly Report · 2018 · 450 citations
- Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo · Nature Medicine · 2024 · 344 citations
- Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022 · MMWR Morbidity and Mortality Weekly Report · 2022 · 335 citations
- Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States · New England Journal of Medicine · 2023 · 304 citations
- Monkeypox Outbreak — Nine States, May 2022 · MMWR Morbidity and Mortality Weekly Report · 2022 · 277 citations
- Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020 · Emerging infectious diseases · 2021 · 229 citations
- Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021 · MMWR Morbidity and Mortality Weekly Report · 2022 · 228 citations
- Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model · Proceedings of the National Academy of Sciences · 2023 · 206 citations
Most recent work
- Tecovirimat for the Treatment of Mpox · New England Journal of Medicine · 2026
- Genomic epidemiology of the 2025 mpox epidemic in Sierra Leone · Nature Medicine · 2026
- Enhanced virulence of mpox virus clade Ib over clade IIb in the CAST/EiJ mouse model · Communications Biology · 2026
- Behavior change and infection induced immunity led to the decline of the 2022 Mpox outbreak in Berlin · Communications Medicine · 2026
- Monkeypox Virus: Epidemiology, Virology, Diagnosis, Vaccine, and Therapeutics · MedComm · 2026
- Evidence of monkeypox virus clade IIb lineage A.2.2 in the Republic of the Congo and co-circulation of clade Ia, Ib and clade IIb · Nature Medicine · 2026
- The Emerging Threat of Monkeypox: An Updated Overview · Viruses · 2026
- An mRNA Vaccine Based on Antigens From Conserved Regions of Monkeypox Virus A35R and M1R With a Dimer‐Like Conformation Confers Protection Against Both Monkeypox Virus and Vaccinia Virus Infections in Mice · MedComm · 2026
- A Humoral Dilemma: Reassessing Monkeypox Virus Neutralizing Antibodies at More Than 2 Years From Mpox or Modified Vaccinia Ankara-Bavarian Nordic Vaccination · The Journal of Infectious Diseases · 2026
- Experiences of stigma among sexual minority men during the 2022 global mpox outbreak. · Psychology of Sexual Orientation and Gender Diversity · 2026
Find a gap in your own Poxvirus research and outbreaks sub-topic
This page shows what the Poxvirus research and outbreaks literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →